Perspective Therapeutics (CATX) Operating Margin (2010 - 2023)

Perspective Therapeutics has disclosed Operating Margin across 14 years of filings, most recently posting 238.19% for Q4 2023.

• Operating Margin for Q4 2023 came in at 238.19%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was 6678.79% (changed N/A YoY), and the FY2023 annual result was 2855.02%, changed N/A from the prior year.
• Operating Margin came in at 238.19% for Q4 2023 at Perspective Therapeutics, up from 446.22% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 238.19% in Q4 2023 to a low of 650.27% in Q2 2023.
• The 5-year median for Operating Margin is 52.17% (2020), against an average of 117.36%.
• Across the five-year window, Operating Margin surged 10184 bps in 2021 and sank 56619 bps in 2023, its largest moves.
• Perspective Therapeutics' Operating Margin stood at 40.93% in 2019, then gained by 10 bps to 37.01% in 2020, then plunged by 57 bps to 58.06% in 2021, then plunged by 322 bps to 245.08% in 2022, then soared by 197 bps to 238.19% in 2023.
• The last three Operating Margin figures came in at 238.19% (Q4 2023), 446.22% (Q3 2023), and 650.27% (Q2 2023), per Business Quant data.